The chemical structure of C21.

C21, also known as VP01 or "Compound 21," is an agonist of the AT2 receptor currently in development by Vicore Pharma.  C21 is being trialed as a drug to treat COVID-19.

C21 is an oral, small molecule drug. C21's CAS # is 477775-14-7. 

See also